Company Intelligence Profile
Ghv Advanced Care Private Limited
GHV Advanced Care Private Limited is the principal operating/holding legal entity behind the "Pristyn Care" brand — a Gurugram-headquartered surgical/elective-care healthcare company founded in 2018 by Harsimarbir Singh, Vaibhav Kapoor and Garima Sawhney.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Ghv Advanced Care Private Limited |
|---|---|
| CIN | U85300HR2018PTC075460 |
| PAN | AAHCG4389A (Tofler) |
| Status | Active |
| Listing | Unlisted (Private Limited Company) |
| Incorporated | 31 August 2018 (Tofler, TheCompanyCheck — confirmed, 2 sources agree) |
| ROC | Conflicting: Tofler states RoC-Haryana; TheCompanyCheck states RoC-Delhi. CIN state code "HR" indicates Haryana registration; historically Haryana companies fall under the combined "Registrar of Companies, NCT of Delhi & Haryana" jurisdiction, which likely explains the discrepancy. Partial/conflict noted. |
| Sector (NIC) | Health and Social Work — Hospital and Medical Care Activities (Tofler) |
| Registered address | 3rd Floor, Capital City Scape, Sector 66, DLF QE, Gurgaon, Haryana, India – 122002 (Tofler, TheCompanyCheck — confirmed) |
| Authorized capital | ₹1.7 Cr (Tofler, TheCompanyCheck — confirmed) |
| Paid-up capital | Conflicting: Tofler ₹72.16 Lakh vs TheCompanyCheck ₹78.74 Lakh (both post-2024; likely a recent allotment between snapshot dates). Reported as partial. |
Business Overview
Confirmed- GHV Advanced Care Private Limited is the principal operating/holding legal entity behind the "Pristyn Care" brand — a Gurugram-headquartered surgical/elective-care healthcare company founded in 2018 by Harsimarbir Singh, Vaibhav Kapoor and Garima Sawhney
- It runs an asset-light surgical-care network (150+ clinics, 800+ partner hospitals per pristyncare.com) and has been building owned/in-house hospitals since 2024-25 (11 owned hospitals, 100+ ICU units as of Oct 2025 per Entrackr)
- It also owns the D2C personal-care brand "beatXp" (via group structure), which contributed ₹267 Cr (2.5x YoY) of FY24 revenue
- Company email on filings: compliances@pristyncare.com, directly tying the legal entity to the Pristyn Care brand
- Sources: Tofler, Entrackr, pristyncare.com
Directors
Partial / conflictingThree directors, all also shareholders, appointed at/near incorporation (confirmed by 2 sources — Tofler, TheCompanyCheck):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Harsimarbir Singh | 03255749 | - | 31 Aug 2018 |
| Vaibhav Kapoor | 08211420 | - | 31 Aug 2018 |
| Garima Sawhney | 08340168 | - | 30 Jan 2019 |
Financials
Partial / conflictingTwo source sets partially conflict — reported separately with attribution:
**Entrackr/Fintrackr (RoC-filing based, "Pristyn Care" consolidated, dated 30 Dec 2024 and 23 Jul 2025 articles) — treated as primary, more granular and dated:**
| FY24 operating revenue | ₹601 Cr (+32.7% YoY); total revenue incl. other income ₹632 Cr |
|---|---|
| FY23 operating revenue | ₹453 Cr; total revenue ₹494 Cr |
| FY24 revenue split | Healthcare services ₹346 Cr (57.5%), D2C/beatXp ₹267 Cr (2.5x YoY) |
| FY24 total expenditure | ₹1,014 Cr (FY23: ₹877 Cr) |
| FY24 net loss | ₹381 Cr (FY23 net loss: ₹383 Cr) — i.e., loss roughly flat YoY despite revenue growth |
| Key FY24 costs | procurement (D2C) ₹253 Cr (up from ₹75 Cr), advertising/marketing ₹183 Cr (-21%), employee benefits ₹192 Cr (-3.5%) |
| Company states FY25 target | ~35% surgery-business growth, ~60% EBITDA improvement, IPO eyed within ~3 years |
**Tofler (standalone balance-sheet extract, as of Mar-2024, partly paywalled) — flagged as conflicting on revenue:**
- Total assets: ₹601.0 Cr; Total liabilities: ₹601.0 Cr
- Borrowings: ₹121.9 Cr (short-term only)
- Equity capital: ₹0.5 Cr; Reserves: ₹272.7 Cr
- Net worth: down 25.21% YoY (consistent with the large net loss reported by Entrackr)
- Tofler's own "operating revenue range" bucket (₹300–400 Cr) and its displayed "Net Profit Margin 36.16%"/positive ROE figures directly conflict with Entrackr's audited-filing-based ₹381 Cr net loss — these Tofler ratio fields appear to be auto-computed/unreliable and are NOT used as the headline figures; Entrackr's RoC-sourced figures are preferred.
Standalone vs consolidated: unclear which basis each source used; flagged as a data gap.
Funding
ConfirmedConfirmed via Entrackr (Jul 2025 exclusive, RoC-filing based):
- Latest round: $4 million, Series E1 CCPS (34,280 shares), issue price ₹10,038.16/share, valuation flat vs prior round — investors Peak XV Partners and Hummingbird Ventures (23 Jul 2025)
- Total funding raised to date (all rounds, as reported by Entrackr): approximately $180 million
- Historical investors named across rounds: Peak XV Partners (formerly Sequoia India), Tiger Global, Hummingbird Ventures, Epiq Capital (round-by-round breakdown/dates beyond the latest round not independently itemized in sources reviewed)
- M&A: acquired Lybrate (Ratan Tata- and Tiger Global-backed) in June 2022 (Entrackr/Inc42)
Not confirmed which legal entity (GHV Advanced Care Pvt Ltd itself vs. a separate holding/Singapore entity) is the formal instrument-issuer of record — treated as a data gap; Tracxn (name-only, per rules) was inaccessible (login-gated).
Charges
Confirmed- Confirmed (Tofler): HDFC Bank Limited — charge of ₹100 Crore created 27 November 2024
- Per source-map convention, "no other open charges shown" does not confirm none exist historically — only that no other open charge appears on the free-tier page
Legal
ConfirmedConfirmed via Indian Kanoon — multiple arbitration/commercial matters, largely GHV Advanced Care as plaintiff against various partner hospitals (consistent with its asset-light hospital-partnership model), plus one Delhi HC matter as defendant:
- Aventus Human Capital Partners LLP vs GHV Advanced Care Pvt Ltd — Delhi HC, 30 Jan 2024 (Judge: Jasmeet Singh)
- Nayati Healthcare and Research NCR Pvt Ltd vs GHV Advanced Care Pvt Ltd — Delhi HC, 8 May 2026
- GHV Advanced Care Pvt Ltd vs Nayati Healthcare and Research NCR Pvt Ltd — Delhi HC, 20 Sep 2023 & 15 Mar 2023 (Judges: Manoj Kumar Ohri, Prateek Jalan)
- GHV Advanced Care Pvt Ltd vs Phoenix Hospital — Punjab-Haryana HC, 23 Jan 2024 (Judge: Suvir Sehgal)
- GHV Advanced Care Pvt Ltd vs Niveda Hospital Pvt Ltd — Punjab-Haryana HC, 23 Jan 2024 (Judge: Suvir Sehgal)
- GHV Advanced Care Pvt Ltd vs Suryadeep Hospital India Pvt Ltd — 5 Nov 2024
- GHV Advanced Care Pvt Ltd vs Gurudev Hospitals Pvt Ltd — 25 Feb 2025
- GHV Advanced Care Pvt Ltd vs Medipark Health Care Pvt Ltd — 22 Apr 2025
- GHV Advanced Care Pvt Ltd vs Time Hospitals Pvt Ltd — 16 Oct 2024
Specific case outcomes not detailed in the Indian Kanoon summary snippets reviewed; these appear to be arbitration-enforcement/commercial disputes with hospital partners rather than regulatory or criminal matters.
Competitors
Partial / conflicting- Practo (tech-enabled healthcare marketplace/consultation platform) — mid-large scale
- Medikabazaar / HealthAssure — adjacent healthcare-services scale players
- Nova IVF / Nova Healthcare / Nova ART & Fertility — elective-surgery/specialty-care chain, comparable scale
- Vinsys/Apollo Sugar or, more directly, Apollo Spectra Hospitals (day-care surgery chain) — comparable elective-surgery model, larger scale (Apollo Group backing)
- SRL Diagnostics/Healthians — adjacent diagnostics-led healthcare platforms, comparable-to-larger scale
- Lybrate — direct former competitor, since acquired by Pristyn Care (Jun 2022), now part of the same group
Named from general market knowledge of India's tech-enabled elective-surgery/day-care hospital space; not source-confirmed as a curated competitor list from any single aggregator.
Frequently Asked Questions
What does Ghv Advanced Care Private Limited do?
What is the CIN of Ghv Advanced Care Private Limited?
Where is Ghv Advanced Care Private Limited registered?
When was Ghv Advanced Care Private Limited incorporated?
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.